Top Markets
Coin of the day
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Rang in Aktien #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Aktienkurs
$0.089
Zuletzt synchronisiert: 2026-08-17
Marktkapitalisierung
$15.36M
Veränderung (1 Tag)
50.59%
Veränderung (1 Jahr)
111.85%
Land
US
Handel Inhibitor Therapeutics, Inc. (INTI)

Kategorie

Aktien-Split-Historie für Inhibitor Therapeutics, Inc. (INTI)
Die Aktie Inhibitor Therapeutics, Inc. (Symbol: INTI) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 18, 2026 statt.
Eine INTI-Aktie, die vor dem Aug 18, 2026 gekauft wurde, entspricht heute 0 INTI-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE